---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-035950"
form_type: "8-K"
ticker: "XAGE"
cik: "0001842939"
company_name: "Longevity Health Holdings, Inc."
filed_at: "2025-03-10T23:59:59+00:00"
generated_at: "2026-05-25T02:05:08.619102+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Carmell rebrands to Longevity Health (XAGE); guides FY25 rev $3-4M; names Vice Chairman

## Summary
- Name change to Longevity Health Holdings effective March 5; tickers to XAGE/XAGEW March 10.
- Patrick Sturgeon appointed Vice Chairman; previously CFO and board director since July 2023.
- Combined sales grew 34% in Jan-Feb 2025 vs 2024 post Elevai acquisition.
- Elevai's post-acquisition burn rate reduced >50% via overhead cost synergies.
- FY25 revenue guidance $3-4M; Q2 2025 product launches include hair growth serum, soapless facial cleanser, etc.

## SEC filing metadata
- accession: 0000950170-25-035950
- form_type: 8-K
- ticker: XAGE
- cik: 0001842939
- company_name: Longevity Health Holdings, Inc.
- filed_at: 2025-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1842939/000095017025035950/0000950170-25-035950-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1842939/000095017025035950/ctcx-20250305.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-035950
- JSON: https://secwatch.observer/filing/0000950170-25-035950.json
- Plain text: https://secwatch.observer/filing/0000950170-25-035950.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.